Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Obstetricia y Ginecología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
ClinicalTrials.gov
Oncological Treatment During Pregnancy: Pharmacokinetics of Chemotherapy and Long Term Follow up of the Offspring
OBSERVATIONAL
Inicio: 1 de ago de 2005
ID: NCT00330447
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 1B/2 Pan-Tumor, Open-Label Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
INTERVENTIONAL
Inicio: 10 de abr de 2024
ID: NCT06330064
Terminado
Fase 2
ClinicalTrials.gov
Phase I Study of the Combination of Trastuzumab Emtansine (T-DM1) and Capecitabine in HER2-Positive Metastatic Breast Cancer and HER2-Positive Locally Advanced/Metastatic Gastric Cancer Patients, Followed by a Randomized, Open-Label Phase II Study of Trastuzumab Emtansine and Capecitabine Versus Trastuzumab Emtansine Alone in HER2-Positive Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 3 de dic de 2012
ID: NCT01702558
Completado
ClinicalTrials.gov
Retrospective Multicenter Observational Study to Evaluate Safety and Effectiveness of Bevacizumab (Avastin®) in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Patients With Advanced Cervical Cancer
OBSERVATIONAL
Inicio: 6 de abr de 2017
ID: NCT03071848
Reclutando
ClinicalTrials.gov
Effectiveness of Post Muscle Inhibition Specific Joint Mobilization on Range of Motion and Pain in Patients With Mechanical Neck Pain
INTERVENTIONAL
Inicio: 30 de ago de 2021
ID: NCT05447338
Desconocido
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter Clinical Trial to Determine the Efficacy, Safety and Tolerability of Peg-filgrastim (Gema) Compared to Peg-filgrastim (Roche) for Prevention of Chemotherapy Induced Neutropenia in Patients With Breast Cancer
INTERVENTIONAL
Inicio: 1 de ago de 2015
ID: NCT03404752
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies
INTERVENTIONAL
Inicio: 22 de mar de 2019
ID: NCT03815643
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Open-Label, Single-Arm Study of Pertuzumab in Combination With Trastuzumab and a Taxane in First Line Treatment of Patients With HER2-Positive Advanced (Metastatic or Locally Recurrent) Breast Cancer
INTERVENTIONAL
Inicio: 1 de jun de 2012
ID: NCT01572038
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Open-label Phase 2 Study of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) in Previously Treated Subjects With Selected Solid Tumors (LEAP-005)
INTERVENTIONAL
Inicio: 12 de feb de 2019
ID: NCT03797326
Desconocido
Fase 3
ClinicalTrials.gov
Immunotherapy of Colon Cancer With Autologous Perchloric Soluble Tumors Extracts
INTERVENTIONAL
Inicio: 1 de abr de 1971
ID: NCT00002455
Completado
ClinicalTrials.gov
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
INTERVENTIONAL
Inicio: 1 de jul de 2007
ID: NCT00428220
Completado
Fase 3
ClinicalTrials.gov
A PHASE 3 RANDOMIZED, DOUBLE-BLIND STUDY OF PF-05280014 PLUS PACLITAXEL VERSUS TRASTUZUMAB PLUS PACLITAXEL FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER
INTERVENTIONAL
Inicio: 24 de feb de 2014
ID: NCT01989676
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Multi-centre, Open-label, Phase III Study of Adjuvant Lapatinib, Trastuzumab, Their Sequence and Their Combination in Patients With HER2/ErbB2 Positive Primary Breast Cancer
INTERVENTIONAL
Inicio: 16 de may de 2007
ID: NCT00490139
Activo, no recluta
Fase 4
ClinicalTrials.gov
A Post-trial Access Roll-over Study to Allow Access to Ribociclib (LEE011) for Patients Who Are on Ribociclib Treatment in Novartis-sponsored Study
INTERVENTIONAL
Inicio: 7 de jul de 2022
ID: NCT05161195
Reclutando
ClinicalTrials.gov
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery: An International, Randomized Superiority Trial (OPBC-10/ NOAX)
INTERVENTIONAL
Inicio: 1 de ene de 2026
ID: NCT07140172
Completado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Multi-center Study to Investigate the Endometrial Safety of a Continuous, Combined, Oral Estrogen/Progestin Preparation (17b-estradiol [E2] / Drospirenone [DRSP]) and to Compare the Bleeding Pattern of Subjects Treated With E2 / DRSP With the Bleeding Pattern of Subjects Treated With E2 / Norethisterone Acetate (NETA) When Used for Hormone Therapy (HT) for 1 Year in Post-menopausal Women
INTERVENTIONAL
Inicio: 1 de ago de 2007
ID: NCT00522873
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma (LEAP-001)
INTERVENTIONAL
Inicio: 11 de abr de 2019
ID: NCT03884101
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK221149A Administered Intravenously and to Investigate the Pharmacokinetics of GSK221149A Administered Orally to Healthy, Pregnant Females With Uncomplicated Pre-term Labor Between 300/7 and 356/7 Weeks' Gestation
INTERVENTIONAL
Inicio: 12 de oct de 2007
ID: NCT00404768
Activo, no recluta
ClinicalTrials.gov
A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America
OBSERVATIONAL
Inicio: 21 de jul de 2023
ID: NCT05857397
Completado
Fase 3
ClinicalTrials.gov
A Randomized Double-blind, Placebo-controlled Study of LEE011 in Combination With Letrozole for the Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2 Negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease
INTERVENTIONAL
Inicio: 17 de dic de 2013
ID: NCT01958021
Anterior
1
...
13
14
15
...
434
Siguiente
Filtros